Jun. 23 at 3:01 PM
$COYA If I didnt already maintain a fairly sizeable and long term position here, and I had capital to deploy, I'd be considering doubling my ownership right here.
For so many fundamental reasons, not limited to balance sheet, line of site to non dilutive funding, their partnership with Dr. Reddy’s, excellent management, marquee investors, low market cap and enterprise value, amazing early study results and multiple near term possobke value creating events like the IND filing by months end, initiating the ALS trial and dosing forst patient receiving milestone payments etc
It has been admittedly a little quiet here, but that is likely to soon change.
